NL-OMON52676撤回不适用
SAFE: Sequre for Adenomyosis and Fibroid Embolisation - SAFE
Sint Elisabeth Ziekenhuis0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- premenopausal woman, age > 30yrs and <= 55yrs
- •- pure adenomyosis, uterine leiomyomata or adenomyosis dominancy with fibroids
- •diagnosed and confirmed with MR imaging.
- •- symptoms e.g. heavy menstrual bleeding, pelvic pain, and bulk related
- •- written informed consent.
排除标准
- •- fibroid >= 5 cm
- •- pregnancy
- •- seeking future pregnancy
- •- presence or suspicion of any gynaecologic malignancy
- •- presence or suspicion of any pelvic inflammatory disease
- •- pelvic congestion syndrome
- •- already infarcted / calcified leiomyomata
- •- bleeding disorder
- •- renal function disorder
研究者
相似试验
已完成
不适用
Randomised trial of gelatin versus embospheres for uterine fibroid embolisatioterine fibroidsLeiomyoma of uterusCancerISRCTN71074145Greater Glasgow and Clyde NHS Board (UK)200
已完成
不适用
Randomised trial of surgery versus fibroid embolisation in the treatment of clinically significant menorrhagiaISRCTN22525542Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
已完成
不适用
EW SPERE: Uterine Fibroid Embolization (UFE) Study Using Newly Designed Embozene MicrospheresUterine Fibroids10013326NL-OMON29773CeloNova BioSciences6
撤回
1 期
Aromatase Inhibitors for Treatment of Uterine LeiomyomasSymptomatic or Large Uterine FibroidsNCT00945360American University of Beirut Medical Center
尚未招募
Unknown
Efficacy and safety of antifibrotic agents for interstitial lung disease associated with rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000052195Yokohama City University Graduate School of Medicine500